Skip to main content

Advertisement

SpringerLink
Log in

Possible reasons for different pattern disappearance of thyroglobulin and thyroid peroxidase autoantibodies in patients with differentiated thyroid carcinoma following total thyroidectomy and iodine-131 ablation

  • Original Articles
  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

Abstract

The purpose of this study was to reveal some possible factors for the differences between the pattern of disappearance of thyroglobulin autoantibodies (anti-Tg) and thyroid peroxidase autoantibodies (anti-TPO) in patients with differentiated thyroid carcinoma following thyroidectomy and iodine-131 ablation. Patients with a history of follicular cell derived cancer (papillary, follicular, both papillary and follicular, Hürthle cell) and high pre-operative titers of anti-TPO and/or anti-Tg autoantibodies were retrospectively studied. Thyroglobulin (Tg) levels were measured using radio-immunometric assay (RIA). Anti-Tg and anti-TPO levels during the first 6 yr’ follow-up were measured by passive agglutination, during the following 10 yr by ELISA method and during the last 2 yr by chemiluminescence assay. A statistically significant difference was observed between median time (72 months) of disappearance of anti-TPO and median time (39 months) of disappearance of anti-Tg in patients with complete ablation of thyroid tissue, following iodine-131 administration (p=0.0395, Logrank statistic=4.24, Kaplan-Meier method). A statistically significant difference was observed between median time (106 months) of disappearance of anti-TPO and median time (33 months) of disappearance of anti-Tg in patients >45 yr of age (p=0.034) and between median time (111 months) of disappearance of anti-TPO and median time (41 months) of disappearance of anti-Tg in patients with tumor size <2 cm (p=0.0175). We concluded that patients with differentiated thyroid carcinoma and pre-surgical elevated titers of both Tg and anti-TPO tend to become earlier anti-Tg seronegative. Although tumor size and age may influence the pattern of thyroid autoantibody reduction, the exact reasons for the different rhythm of autoantibodies decrease must further be evaluated.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Torrens J, Burch H. Serum Tg measurement. Utility in clinical practice. Endocrinol Metab Clin North Am 2001, 30: 429–67.

    Article  PubMed  CAS  Google Scholar 

  2. Chung JK, Park YJ, Kim TY, et al. Clinical significance of elevated level of serum Anti Tg in patients with DTC after thyroid ablation. Clin Endocrinol (Oxf) 2002, 57: 21 5–21.

    Google Scholar 

  3. Rodien P, Madec AM, Ruf J, et al. Antibody-dependent cell-mediated cytotoxicity in autoimmune thyroid disease: relationship to antithyroperoxidase antibodies. J Clin Endocrinol Metab 1996, 81: 2595–600.

    PubMed  CAS  Google Scholar 

  4. Baker J, Fosso CK. Immunological aspects of cancers arising from thyroid follicular cells. Endocr Rev 1993, 14: 729–46.

    PubMed  Google Scholar 

  5. Spencer CA, Takeuchi M, Kazarosyan M, et al. Serum thyroglobulin autoantibodies: prevalence, influence on serum thyroglobulin measurement, and prognostic significance in patients with differentiated thyroid carcinoma. J Clin Endocrinol Metab 1998, 83: 1121–7.

    PubMed  CAS  Google Scholar 

  6. Hocevar M, Auersperg M, Stanovnik L. The dynamics of serum thyroglobulin elimination from the body after thyroid surgery. Eur J Surg Oncol 1997, 23: 280–10.

    Article  Google Scholar 

  7. Chiovato L, Latrofa F, Braverman LA, et al. Disappearance of humoral thyroid autoimmunity after complete removal of thyroid antigens. Ann Intern Med 2003, 139: 346–51.

    Article  PubMed  CAS  Google Scholar 

  8. Sheils OM, O’Eary J, Uhlmann V, Lattich K, Sweeny EC. Ret/ PTC-1 activation in Hashimoto thyroiditis. Int J Surg Pathol 2000,8:185–92.

    Article  PubMed  CAS  Google Scholar 

  9. Powel DJ, Eisenlohr LC, Rothstein JL. A thyroid tumor-specific antigen formed by the fusion of two self-proteins. J Immunol 2003, 170: 861–9.

    Article  Google Scholar 

  10. Tomer Y, Davies TF. Infection, thyroid disease and autoimmunity. Endocr Rev 1993, 14: 107–20.

    PubMed  CAS  Google Scholar 

  11. Fountoulakis S, Tsatsoulis A. On the pathogenesis of autoimmune thyroid disease: a unifying hypothesis. Clin Endocrinol (Oxf) 2004, 60: 397–409.

    Article  Google Scholar 

  12. Tsatsoulis A. The role of apoptosis in thyroid disease. Minerva Med 2002, 93: 169–80.

    PubMed  CAS  Google Scholar 

  13. Armengol MP, Juan M, Lucas-Martin A, et al. Demonstration of thyroid antigen-specific B cells and recombination-activating gene expression in cheomokine-containing active intrathyroidal germinal centers. Hum Pathol 2001, 159: 861–73.

    CAS  Google Scholar 

  14. Ringel MD, Ladenson PW, Levine MA. Molecular diagnosis of residual and recurrent thyroid cancer by amplification of thyroglobulin messenger ribonucleic acid in peripheral blood. J Clin Endocrinol Metab 1998, 83: 4435–42.

    PubMed  CAS  Google Scholar 

  15. Oliviery A, Marzullo A, Salbe GB, Gilardi E, Faccini C, Carta S. Isoelectric focusing and immunoblotting analysis of thyroglobulin from different thyroid disease. Thyroidol 1991, 3: 13–6.

    Google Scholar 

  16. Fugazzola L, Michalich A, Persani L, et al. High sensitive serum thyroglobulin and circulating thyroglobulin mRNA evaluations in the management of patients with differentiated thyroid cancer in apparent remission. J Clin Endocrinol Metab 2002, 87: 3201–8.

    Article  PubMed  CAS  Google Scholar 

  17. Bugalho MJ, Domingues RS, Pinto AC, et al. Detection of thyroglobulin mRNAs transcripts in peripheral blood of individuals with and without thyroid glands: evidence for thyroglobulin expression by blood cells. Eur J Endocrinol 2001, 145: 409–13.

    Article  PubMed  CAS  Google Scholar 

  18. Macsween KF, Crawford DH. Epstein-Barr virus recent advances. Lancet Infect Dis 2002, 3: 131–40.

    Article  Google Scholar 

  19. Nakamura M, Burastero SE, Ueki Y, Larrick JW, Notkins AL, Casali P. Probing the normal and autoimmune B cell repertoire with Epstein-Barr virus. Frequency of B cells producing monoreactive high affinity autoanibodies in patients with Hashimoto’s disease and systemic lupus erythematosus. J Immunol 1998, 141: 4165–72.

    Google Scholar 

  20. MacLahlan SM, Rapaport B. Evidence for a potential common T cell epitope between human thyroid peroxidase and human thyroglobulin with implications for the pathogenesis of autoimmune thyroid disease. Autoimmunity 1989, 5: 101–6.

    Article  Google Scholar 

  21. Vojdani A, Rahimian P, Kahlor H, Mordechai E. Immunological cross reactivity between Candida albicans and human tissue. J Clin Lab Immunol 1996, 48: 1–15.

    PubMed  CAS  Google Scholar 

  22. Bertalot G, Montresor G, Tampieri M, et al. Decrease in thyroid autoantibodies after eradication of Helicobacter pylori infection. Clin Endocrinol (Oxf) 2004, 61: 650–2.

    Article  Google Scholar 

  23. Villiers MB, Marche PN, Villiers CL. Improvement of long-lasting response and antibody affinity by the complexation of antigen with complement C3b. Inter Immunol 2003, 15: 91–5.

    Article  CAS  Google Scholar 

  24. Nakra P, Manivel V, Vishwakarma RA, Rao KVS. B cell responses to a peptide epitope. X. Epiotope selection in a primary response is thermodynamically regulated. J Immunol 2000, 164: 5615–25.

    Article  PubMed  CAS  Google Scholar 

  25. Inaoki M, Sato S, Weitraub BC, Goodnow CC, Tedder TF. CD-19 regulated thresholds control peripheral tolerance and autoantibody production in B lymphocytes. J Exp Med 2000, 186: 1923–31.

    Article  Google Scholar 

  26. Fecteau JF, Neron S. CD40 stimulation of human peripheral B lymphocytes: distinct responses of naïve and memory B lymphocytes. J Immunol 2003, 171: 4621–9.

    Article  PubMed  CAS  Google Scholar 

  27. Barzon L, Boscaro M, Pacenti M, Taccaliti A, Palu G. Evaluation of circulating thyroid-specific transcripts as markers of thyroid cancer. Int J Cancer 2004, 110: 914–20.

    Article  PubMed  CAS  Google Scholar 

  28. Ma C, Kuang J, Xie J, Ma T. Possible explanations for patients with discordant findings of serum thyroglobulin and 131I whole body scanning. J Nucl Med 2005, 46: 1473–80.

    PubMed  CAS  Google Scholar 

  29. Hobby P, Gardas A, Radomski R, McGregor AM, Banga JB, Sutton BJ. Identification of an immunodominant region recognized by human autoantibodies in a three-dimensional model of thyroid peroxidase. Endocrinology 2000, 141: 2018–26.

    PubMed  CAS  Google Scholar 

  30. Bresson D, Cerutti M, Devauchelle G, et al. Localization of the discontinuous immunodominant region recognized by human anti-thyroperoxidase autoantibodies in autoimmune thyroid diseases. J Biol Chem 2003, 278: 9560–9.

    Article  PubMed  CAS  Google Scholar 

  31. Hammer J, Belunis C, Bolin D, et al. High-affinity binding of short peptides to major histocompatibility complex class II molecules by anchor combinations. Proc Natl Acad Sci 1994, 91: 4456–62.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  32. Garcia KC, Teyton L, Wilson IA. Structural basis of T cell recognition. Ann Rev Immunol 1999, 17: 369–97.

    Article  CAS  Google Scholar 

  33. Schneider F, Mariotti S, Ikekubo K, Kuma K. Iodine content of serum thyroglobulin in normal individuals and patients with thyroid cancer. J Clin Endocrinol Metab 1985, 57: 1251–6.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Endocrinology, Diabetes and Metabolism, “Metaxa” Memorial Anticancer Research Hospital, Botasi 51, 18537, Piraeus, Greece

    D. Thomas MD, V. Liakos, E. Vassiliou, F. Hatzimarkou & P. Kaldrimides

  2. Division of Endocrinology, Department of Medicine, University of Ioannina, Ioannina, Greece

    V. Liakos, E. Vassiliou & A. Tsatsoulis

Authors
  1. D. Thomas MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. V. Liakos
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. E. Vassiliou
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. F. Hatzimarkou
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. A. Tsatsoulis
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. P. Kaldrimides
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to D. Thomas MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Thomas, D., Liakos, V., Vassiliou, E. et al. Possible reasons for different pattern disappearance of thyroglobulin and thyroid peroxidase autoantibodies in patients with differentiated thyroid carcinoma following total thyroidectomy and iodine-131 ablation. J Endocrinol Invest 30, 173–180 (2007). https://doi.org/10.1007/BF03347421

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03347421

Key Words

Search

Navigation